Central Laboratories Applications & Studies
-
Real-World Data Capture With EDC
5/20/2022
This case study explores how a Ph.D. candidate partnered with Castor to develop software that seamlessly moves RWD between hospital systems and Castor’s EDC.
-
Fujirebio Increases Study Agility By Streamlining Clinical Operations And Data Management Process
3/2/2022
Fujirebio’s fast-growing U.S. Clinical R&D team was preparing for shorter studies with higher complexity. Traditional methods using paper and spreadsheet trackers were no longer adequate to meet quality goals. Learn how the group increased its agility and readiness with LifeSphere Clinical EDC and CTMS tools.
-
Using De-Identified Linked Real-World Data To Create An External Control Arm In Non-Small Cell Lung Cancer
12/16/2021
A pharmaceutical company designed its Phase II study of a novel agent to treat metastatic non-small cell lung cancer driven by a rare subtype of EGFR genetic mutation. Discover the results in the available case study.
-
Expert Analysis Of Rater Discrepancies Allows Sponsor To Demonstrate Efficacy (Even With A Missing Endpoint)
9/15/2021
Discover how a sponsor gained the confidence required to proceed with the development of their movement disorder compound.
-
Case Study – Leading Pharma Enrolls 56% Faster With WCG Site Augmentation
9/8/2021
A leading sponsor initiated a time-critical and complex adult Staphylococcus vaccine study. Per the protocol design, this global study needed to address patient identification and coordination of communication pathways for referral networking. The study also required real-time review of daily surgical schedules to assess patients’ eligibility.
-
Visual Analytics And Discovery Platform For Scientific And Clinical R&D
8/18/2021
A pharmaceutical company was looking to deploy a software solution for a small R&D group. See how an enterprise-class visualization and analytics platform enabled maximized understanding of research data.
-
UW Carbone Cancer Center Gains Visibility Into Site Accrual
5/11/2021
Monitoring accrual is a key responsibility for a cancer center administrator. From answering questions for leadership to preparing for a grant submission, knowing the ins and outs of a site’s accrual metrics can ensure greater operational efficiencies center-wide. Read how UWCCC was able to enhance their data analytics and visualization capabilities helping them improve operational oversight, especially through greater visibility into site accrual metrics.
-
Preparing Data For The Marketing Authorization Application (MAA) Of A Recently Acquired Product
4/28/2021
A mid-sized biopharmaceutical company dedicated to developing innovative therapies for patients with debilitating rare diseases acquired the rights to a new investigational drug from a large pharmaceutical company with the intention of preparing the data for a Marketing Authorization Application (MAA). Learn how our team had to think creatively to enter, clean and standardize the clinical trial data from previous and ongoing trials in order to get the MAA ready for submission in an extremely short timeline.
-
Real World Data: Extensive Searchable Selection Tables For Sites In A Study With 15,000 Patients
4/7/2021
A top 5 Pharma company was collecting data for a global disease registry from over 10,000 patients. To avoid collecting “free text” they wanted the study sites to use extensive “pick lists”. These lists consisted of over 12,000 unique options so could not be just simple lists. Cmed was able to provide a solution that would enable site staff to review, filter and select the required option.
-
Reduce Time, Cost, & Risk With Clinical Study Data Review Software
1/22/2021
See how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.